Summary & Overview
HCPCS J7650: Isoetharine HCl Inhalation Solution, Unit-Dose, DME
HCPCS Level II code J7650 denotes isoetharine hydrochloride inhalation solution prepared as a compounded, unit-dose product and administered via durable medical equipment. The code captures a niche pharmacologic delivery method for bronchodilator therapy used in outpatient and home DME settings. Nationally, codes for compounded inhalation solutions are important for billing precision, pharmacy compounding oversight, and payer coverage determinations because they affect reimbursement, clinical documentation, and DME workflows.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for isoetharine inhalation therapy, typical sites of service tied to DME administration, and the billing contours associated with a compounded, unit-dose inhalation product. The publication summarizes expected coding use, the administrative interface with DME claims, and common considerations payers apply when adjudicating compounded inhalation medications.
This summary equips billing managers, pharmacy directors, and reimbursement analysts with the foundational information needed to align documentation, pharmacy compounding records, and DME claims for J7650. Data not available in the input is noted where relevant.
Billing Code Overview
HCPCS Level II code J7650 describes Isoetharine HCl, inhalation solution, compounded product, administered through DME, unit dose form, per milligram. This entry represents a pharmaceutical administration service for a bronchodilator solution prepared as a compounded, unit-dose inhalation formulation. The service is typically associated with durable medical equipment (DME) delivery and administration, with the typical site of service being home or other outpatient settings where DME is used to deliver inhalation therapy.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with acute bronchospasm due to reactive airway disease or chronic obstructive pulmonary disease (COPD) who requires inhaled short-acting beta-2 agonist therapy delivered via unit-dose solution through durable medical equipment (DME) such as a nebulizer. In the ambulatory DME setting a respiratory therapist or trained home health clinician prepares or administers a compounded J7650 isoetharine HCl inhalation solution for patients who cannot reliably use handheld metered-dose inhalers or require direct supervision for nebulized therapy. The workflow begins with a prescriber order for isoetharine solution including dose and frequency, verification of insurance and DME coverage, preparation or compounding of the unit-dose solution, delivery to the patient or administration in the clinic/home, documentation of the medication lot, dose administered, route (nebulization via DME), and any patient response or adverse events. Billing is submitted using HCPCS code J7650 per milligram for the compounded unit-dose inhalation solution, with appropriate modifiers applied for unusual circumstances, place of service, or payer-specific requirements.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — standard billing | Use when no special circumstances apply and the service is routine. |